O-Glycoprotease (IMPa) is a broad specificity protease that cleaves the peptide bonds of a glycoprotein or glycopeptide immediately N-terminal to a serine or threonine residue containing a mucin-type O-linked glycan with or without sialylation.
O-Glycoprotease (IMPa), also known as Immunomodulating protease (IMPa), is a broad specificity O-glycoprotease from Pseudomonas aeruginosa. It recognizes mucin-type O-glycans in glycoproteins or glycopeptides, including branched and sialylated structures, and cleaves the peptide bond immediately N-terminal to a glycosylated serine or threonine residue. It can be used in glycoproteomics workflows to map O-glycosylated residues and structurally profile O-glycans present at each glycosite. O-Glycoprotease (IMPa) has a 6xHis-tag for easy removal from a reaction using nickel affinity resins.
Products and content are covered by one or more patents, trademarks and/or copyrights owned or controlled by New England Biolabs, Inc (NEB). The use of trademark symbols does not necessarily indicate that the name is trademarked in the country where it is being read; it indicates where the content was originally developed. The use of this product may require the buyer to obtain additional third-party intellectual property rights for certain applications. For more information, please email busdev@neb.com.
This product is intended for research purposes only. This product is not intended to be used for therapeutic or diagnostic purposes in humans or animals.
New England Biolabs (NEB) is committed to practicing ethical science – we believe it is our job as researchers to ask the important questions that when answered will help preserve our quality of life and the world that we live in. However, this research should always be done in safe and ethical manner. Learn more.